CASE STUDY. Going further, Investment is the process of capital creation and as any banker like Parvez Balaporia will remind us, is only viable when (i) < (r). That is to say, the rate of return is more than the cost of borrowing. Hence exploiting the resources is built into the economist's paradigm. Is HR really exploitative when we seek to enhance internal customer satisfaction and promote a healthy work environment? Alternatively, is the exploitation so subtle that it is not perceived? This takes us into value Based Management. The above notwithstanding, we could emphatically state that the HR expert can and should obviate this problem by ensuring that human development takes place all the time, that value addition is universal and employees are proud to belong to the organization. This issue of belongingness, we shall address later, but for now let it be noted that belongingness means two things: The organization belongs to me and also I belong to this organization. This comes from giving respect to the human being even when differing with his/her views. Concern for the individual is the hallmark of a good leader. The HR expert is above all a leader and a producer of leaders through his facilitation. Once this is achieved, the task of converting core competence into competitive advantage becomes relatively simple. Before we jump to the conclusion that HRM is an end in itself, let the premise upon which we act be made absolutely clear. To the positive economist HRM is a behavioral interpretation of the various ramifications brought about by the micro production function. That is taking things a little off the track. What we say is that the organization is a microcosm of the larger society and is a part of the political economy within which it exists.

Question 41 What is the difference between transudate and exudate?

Question 42 I wish to ask about Meigs' syndrome. I know that it is an association of pleural effusion, ascites and benign ovarian tumours or fibromas. Is the effusion transudate or exudate?

Question 43 I have read that patients with cystic fibrosis should not meet each other socially. Why is this?

Question 44 I have a young patient with bilateral hilar lymphadenopathy but no other manifestations of sarcoidosis. How can I make a diagnosis?

Question 45 We have read in your book that continuous oxygen therapy at home reduces mortality in chronic obstructive pulmonary disease (COPD). I am concerned that my patient might develop acute respiratory failure.

Question 46 I have a patient with asthma who is on long-term inhaled corticosteroids. She is very concerned about long-term steroid therapy. Could I replace the steroids with a long-acting beta2 agonist?

Question 47 What is the role of leukotriene-modifying agents in asthma?

Question 48 Is it true that the Mantoux test is no longer used?

Question 49 Is there a screening test that is useful for the diagnosis of lung cancer?

Question 50 For how long should treatment be continued for cervical lymphadenopathy and abdominal tuberculosis? What role, if any, do steroids play in the treatment of these conditions?